BPC-157 and TB-500: Combination Overview

BPC-157 and TB-500 are the two peptides most frequently studied as a pair in tissue-organisation research. This overview explains why the two are commonly catalogued together and how their mechanisms differ.

Why BPC-157 and TB-500 Are Studied Together

The two compounds are studied as a pair because their described mechanisms operate on different scales. BPC-157 is generally characterised as acting locally; TB-500, a fragment-analogue of Thymosin Beta-4, is the more systemically distributed of the two. Researchers examining tissue-organisation and cell-migration pathways frequently catalogue them together for that reason — one targeted, one broad.

BPC-157

BPC-157 is a synthetic 15-amino-acid peptide derived from a protein found in gastric juice, studied across a range of preclinical tissue-organisation contexts.

TB-500

TB-500 is a synthetic peptide based on a fragment of Thymosin Beta-4, studied for its role in actin regulation and cell migration.

Forms, Purity and Handling

• Format: lyophilised powder.

• Purity: greater than or equal to 99% by HPLC.

• COA: per batch.

• Storage: frozen for long-term stability; refrigerated once in solution.

Frequently Asked Questions

Why are BPC-157 and TB-500 studied together?

Their mechanisms operate on different scales — BPC-157 local, TB-500 systemic — so they are catalogued as a pair.

What is the difference between them?

BPC-157 is generally characterised as acting locally; TB-500 is more systemically distributed.

What purity should they be?

Greater than or equal to 99% by HPLC with a per-batch COA for each.

These products are supplied strictly for laboratory and research use only. Not for human or animal consumption.